Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
908 DevicesMASS +8.11%74 EV-to-OCF is -27.40 as of Jul. 29, 2026. GuruFocus rates MASS with a GF Score™ of 74/100 and a GF Value™ of $7.05 (Fairly Valued). The stock has 6 warning signs investors should review. Among 852 Medical Devices & Instruments companies, 908 Devices ranks better than 89.2% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, 908 Devices's Enterprise Value is $204.53 Mil.
908 Devices's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $-7.46 Mil. Therefore, 908 Devices's EV-to-OCF for today is -27.40.
The historical rank and industry rank for 908 Devices's EV-to-OCF or its related term are showing as below:
MASS'
s EV-to-OCF Range Over the Past 10 Years
Min: -565.08 Med: -4.23 Max: 861.78
Current: -27.4
During the past 8 years, the highest EV-to-OCF of 908 Devices was 861.78. The lowest was -565.08. And the median was -4.23.
MASS's EV-to-OCF is ranked better than 89.2% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 7.81
vs MASS: -27.40
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
908 Devices's PE Ratio (TTM) for today is calculated as:
908 Devices's share price for today is $7.59.
908 Devices's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
908 Devices EV-to-OCF Related Terms
908 Devices EV-to-OCF Historical Data
* Premium members only.
The historical data trend for 908 Devices's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, 908 Devices's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
908 Devices EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 908 Devices's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where 908 Devices's EV-to-OCF falls into.
908 Devices's current Enterprise Value is $204.53 Mil.
908 Devices's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.46 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
908 Devices (MASS) has a EV-to-OCF of -27.40 as of Jul. 29, 2026. According to the industry distribution chart, 908 Devices ranks #92 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 10.8%.
Is 908 Devices' EV-to-OCF too high?
908 Devices' current EV-to-OCF is -27.40. Based on the distribution chart, 908 Devices ranks #92 out of 852 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, 908 Devices has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does 908 Devices' EV-to-OCF compare to ELMD and SGHT?
According to the Medical Devices & Instruments industry distribution chart, 908 Devices ranks #92 out of 852 companies for EV-to-OCF. This places 908 Devices in the top 11% of its industry — outperforming the majority of peers. The industry median EV-to-OCF is 7.81. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.81, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 908 Devices's current EV-to-OCF is -27.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 908 Devices stock overvalued right now?
Based on GuruFocus' analysis, 908 Devices (MASS) is currently considered Fairly Valued. The stock's GF Value™ is $7.05, compared to a current price of $7.59 — trading 7.7% above its estimated fair value. The current EV-to-OCF is -27.40. 908 Devices' overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For 908 Devices (MASS), the current EV-to-OCF is -27.40 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 908 Devices (MASS) Overvalued in 2026?
Based on GuruFocus' analysis, 908 Devices stock appears to be overvalued.
The current stock price of $7.59 is trading 7.7% above its estimated GF Value™ of $7.05.
GuruFocus considers 908 Devices to be Fairly Valued.
Key valuation signals for MASS:
EV-to-OCF: -27.40
GF Value™: $7.05 vs. price of $7.59 (7.7% above fair value)
No single metric tells the full story. See the MASS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
74GF Score
Get the complete analysis for MASS
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MASS has been successfully added to your 
